Oxidative folding and structural analyses of a Kunitz-related inhibitor and its disulfide intermediates: functional implications.

Tick-derived protease inhibitor (TdPI) is a tight-binding Kunitz-related inhibitor of human tryptase β with a unique structure and disulfide-bond pattern. Here we analyzed its oxidative folding and reductive unfolding by chromatographic and disulfide analyses of acid-trapped intermediates. TdPI folds through a stepwise generation of heterogeneous populations of one-disulfide, two-disulfide, and three-disulfide intermediates, with a major accumulation of the nonnative three-disulfide species IIIa. The rate-limiting step of the process is disulfide reshuffling within the three-disulfide population towards a productive intermediate that oxidizes directly into the native four-disulfide protein. TdPI unfolds through a major accumulation of the native three-disulfide species IIIb and the subsequent formation of two-disulfide and one-disulfide intermediates. NMR characterization of the acid-trapped and further isolated IIIa intermediate revealed a highly disordered conformation that is maintained by the presence of the disulfide bonds. Conversely, the NMR structure of IIIb showed a native-like conformation, with three native disulfide bonds and increased flexibility only around the two free cysteines, thus providing a molecular basis for its role as a productive intermediate. Comparison of TdPI with a shortened variant lacking the flexible prehead and posthead segments revealed that these regions do not contribute to the protein conformational stability or the inhibition of trypsin but are important for both the initial steps of the folding reaction and the inhibition of tryptase β. Taken together, the results provide insights into the mechanism of oxidative folding of Kunitz inhibitors and pave the way for the design of TdPI variants with improved properties for biomedical applications.

[1]  K. Wüthrich NMR of proteins and nucleic acids , 1988 .

[2]  H. Scheraga,et al.  Structural characterization of an analog of the major rate-determining disulfide folding intermediate of bovine pancreatic ribonuclease A. , 1997, Biochemistry.

[3]  P. S. Kim,et al.  Reexamination of the folding of BPTI: predominance of native intermediates , 1991, Science.

[4]  J. Otlewski,et al.  The many faces of protease–protein inhibitor interaction , 2005, The EMBO journal.

[5]  Robert F Gahl,et al.  Oxidative folding pathway of onconase, a ribonuclease homologue: insight into oxidative folding mechanisms from a study of two homologues. , 2009, Biochemistry.

[6]  W. Bode,et al.  The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Wüthrich,et al.  Structure and internal dynamics of the bovine pancreatic trypsin inhibitor in aqueous solution from long‐time molecular dynamics simulations , 1995, Proteins.

[8]  Paolo Ascenzi,et al.  The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. , 2003, Current protein & peptide science.

[9]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[10]  K Wüthrich,et al.  NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata , 1994, FEBS letters.

[11]  S. Macedo-Ribeiro,et al.  Tick-derived Kunitz-type inhibitors as antihemostatic factors. , 2009, Insect biochemistry and molecular biology.

[12]  J F Morrison,et al.  Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. , 1969, Biochimica et biophysica acta.

[13]  H. Scheraga,et al.  Regeneration of bovine pancreatic ribonuclease A: identification of two nativelike three-disulfide intermediates involved in separate pathways. , 1998, Biochemistry.

[14]  Jui-Yoa Chang,et al.  Structure and Heterogeneity of the One- and Two-Disulfide Folding Intermediates of Tick Anticoagulant Peptide , 2000, Journal of protein chemistry.

[15]  T. Creighton,et al.  On the biosynthesis of bovine pancreatic trypsin inhibitor (BPTI). Structure, processing, folding and disulphide bond formation of the precursor in vitro and in microsomes. , 1993, Journal of molecular biology.

[16]  R. Huber,et al.  Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. , 1998, Nature.

[17]  T. Creighton,et al.  Refolding of bovine pancreatic trypsin inhibitor via non-native disulphide intermediates. , 1995, Journal of molecular biology.

[18]  H. Scheraga,et al.  Regeneration of bovine pancreatic ribonuclease A: detailed kinetic analysis of two independent folding pathways. , 1998, Biochemistry.

[19]  C. Sommerhoff Mast cell tryptases and airway remodeling. , 2001, American journal of respiratory and critical care medicine.

[20]  F. Avilés,et al.  Deciphering the Structural Basis That Guides the Oxidative Folding of Leech-derived Tryptase Inhibitor* , 2009, The Journal of Biological Chemistry.

[21]  A. Mark,et al.  The structure of a two-disulfide intermediate assists in elucidating the oxidative folding pathway of a cyclic cystine knot protein. , 2008, Structure.

[22]  H. Scheraga,et al.  Kinetic folding pathway of a three-disulfide mutant of bovine pancreatic ribonuclease A missing the [40-95] disulfide bond. , 1998, Biochemistry.

[23]  F. Avilés,et al.  Oxidative folding of leech-derived tryptase inhibitor via native disulfide-bonded intermediates. , 2008, Antioxidants & redox signaling.

[24]  J. Chang The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI. , 1996, Biochemistry.

[25]  Mohammad M. Islam,et al.  Crystal structure of an extensively simplified variant of bovine pancreatic trypsin inhibitor in which over one-third of the residues are alanines , 2008, Proceedings of the National Academy of Sciences.

[26]  Jui-Yoa Chang,et al.  Diverse pathways of oxidative folding of disulfide proteins: underlying causes and folding models. , 2011, Biochemistry.

[27]  M. Qasim,et al.  What can the structures of enzyme-inhibitor complexes tell us about the structures of enzyme substrate complexes? , 2000, Biochimica et biophysica acta.

[28]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .

[29]  J. Bieth Pathophysiological interpretation of kinetic constants of protease inhibitors. , 1980, Bulletin europeen de physiopathologie respiratoire.

[30]  G. Pejler,et al.  Biology of mast cell tryptase , 2006 .

[31]  R. Huber,et al.  The Three-dimensional Structure of Recombinant Leech-derived Tryptase Inhibitor in Complex with Trypsin , 1997, The Journal of Biological Chemistry.

[32]  David I Stuart,et al.  A tick protein with a modified Kunitz fold inhibits human tryptase. , 2007, Journal of molecular biology.

[33]  R. Huber,et al.  Human β-tryptase is a ring-like tetramer with active sites facing a central pore , 1998, Nature.

[34]  M. Karplus,et al.  A conformational isomer of bovine pancreatic trypsin inhibitor protein produced by refolding , 1980, Nature.

[35]  N. Rawlings Peptidase inhibitors in the MEROPS database. , 2010, Biochimie.

[36]  Harold A. Scheraga,et al.  Mechanism of reductive protein unfolding , 1995, Nature Structural Biology.

[37]  H. Scheraga,et al.  Regeneration of three-disulfide mutants of bovine pancreatic ribonuclease A missing the 65-72 disulfide bond: characterization of a minor folding pathway of ribonuclease A and kinetic roles of Cys65 and Cys72. , 1998, Biochemistry.

[38]  G. Pejler,et al.  Biology of mast cell tryptase. An inflammatory mediator. , 2006, The FEBS journal.

[39]  G. Fendrich,et al.  Purification, characterization and biological evaluation of recombinant leech-derived tryptase inhibitor (rLDTI) expressed at high level in the yeast Saccharomyces cerevisiae. , 1996, European journal of biochemistry.

[40]  H. Scheraga,et al.  Disulfide bonds and protein folding. , 2000, Biochemistry.

[41]  P. Güntert Automated NMR structure calculation with CYANA. , 2004, Methods in molecular biology.

[42]  F. Avilés,et al.  Designing out disulfide bonds of leech carboxypeptidase inhibitor: implications for its folding, stability and function. , 2009, Journal of molecular biology.

[43]  C. Sommerhoff,et al.  Mast cell tryptase beta as a target in allergic inflammation: an evolving story. , 2007, Current pharmaceutical design.

[44]  E. Auerswald,et al.  A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis. , 1994, Biological chemistry Hoppe-Seyler.

[45]  M. Laskowski,et al.  THE BASIC TRYPSIN INHIBITOR OF BOVINE PANCREAS. IV. THE LINEAR SEQUENCE OF THE 58 AMINO ACIDS. , 1965, Biochemical and biophysical research communications.

[46]  M. Laskowski,et al.  The basic trypsin inhibitor of bovine pancreas. V. The disulfide linkages. , 1965, Biochemical and biophysical research communications.

[47]  W. Bode,et al.  The human mast cell tryptase tetramer: a fascinating riddle solved by structure. , 2000, Biochimica et biophysica acta.

[48]  Jui-Yoa Chang,et al.  The structure of denatured bovine pancreatic trypsin inhibitor (BPTI) , 2000, FEBS letters.

[49]  Jui-Yoa Chang Distinct folding pathways of two homologous disulfide proteins: bovine pancreatic trypsin inhibitor and tick anticoagulant peptide. , 2011, Antioxidants & redox signaling.

[50]  H. Scheraga,et al.  Structural determinants of oxidative folding in proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  T. Holak,et al.  NMR structural characterization and computational predictions of the major intermediate in oxidative folding of leech carboxypeptidase inhibitor. , 2005, Structure.

[52]  F. Avilés,et al.  Role of Kinetic Intermediates in the Folding of Leech Carboxypeptidase Inhibitor* , 2004, Journal of Biological Chemistry.

[53]  E. Shaw,et al.  [2] Titration of trypsin, plasmin, and thrombin with p-nitrophenyl p′-guanidinobenzoate HCl☆ , 1970 .

[54]  R. Huber,et al.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. , 1973, Journal of molecular biology.

[55]  Bruce A. Johnson,et al.  NMR View: A computer program for the visualization and analysis of NMR data , 1994, Journal of biomolecular NMR.

[56]  T. Creighton,et al.  The disulfide folding pathway of BPTI. , 1992, Science.

[57]  P. S. Kim,et al.  Contribution of individual side-chains to the stability of BPTI examined by alanine-scanning mutagenesis. , 1995, Journal of molecular biology.

[58]  J. Cairns Inhibitors of mast cell tryptase beta as therapeutics for the treatment of asthma and inflammatory disorders. , 2005, Pulmonary pharmacology & therapeutics.

[59]  J. Thornton,et al.  AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.

[60]  E. Querol,et al.  Analysis of the effect of potato carboxypeptidase inhibitor pro-sequence on the folding of the mature protein. , 2003, European journal of biochemistry.

[61]  F. Avilés,et al.  Folding of small disulfide-rich proteins: clarifying the puzzle. , 2006, Trends in biochemical sciences.

[62]  D. Goldenberg,et al.  Functional and structural roles of the Cys14-Cys38 disulfide of bovine pancreatic trypsin inhibitor. , 2008, Journal of molecular biology.

[63]  M. Czisch,et al.  Structure of leech derived tryptase inhibitor (LDTI‐C) in solution , 1994, FEBS letters.

[64]  S. Ventura,et al.  Protease inhibitors as models for the study of oxidative folding. , 2011, Antioxidants & redox signaling.

[65]  Jui-Yoa Chang Denatured States of Tick Anticoagulant Peptide , 1999, The Journal of Biological Chemistry.